SOURCE: Press Ventures

September 10, 2013 18:23 ET

Press Ventures, Inc. Secures Long-Term Commercial Supply of Western Cedar Oil

WARSAW, POLAND--(Marketwired - Sep 10, 2013) - Biosafety Systems, Inc. Sp z o.o, a wholly owned Polish subsidiary of Press Ventures Inc. (OTCQB: PVEN) ("Press Ventures" or the "Company"), has secured an expanded long-term commercial supply of cedar oil for its patented Cedar Leaf Oil Diffusion ("CLO-D") system.

The Company has received considerable interest to test its CLO-D system in many different locations worldwide. The immediate demand for potential installations required the Company to secure large volumes of cedar oil for its expanding customer base. To meet the projected demand, Biosafety Systems has reached an agreement with Dr. David Jones of Coastal Char Industries (CCI), which will provide the Company with top quality organic cedar oil from sustainable North American forests.

The gathering of oil from the cedar tree is actually considered positive for the health of the tree and assists nature in its stronger growth. No harm is done to the cedar tree during the oil gathering process.

Press Ventures' CEO, Mr. Edward Denkewieicz, commented, "With a view towards global expansion underway, there has been a significant increase in demand for our patented CLO-D bacteria and virus killing technology globally. Securing large commercial volumes of high quality western cedar oil is an important strategic breakthrough because it will enable us to ramp up our testing and client base in an efficient and rapid manner. We look forward to working with Dr. David Jones from CCI for many years as we develop CLO-D technology around the world."

About Press Ventures

Press Ventures holds the worldwide rights to the patented Cedar Leaf Oil Diffusion ("CLO-D") technology for the use of natural products to kill bacteria, mold, and viruses in buildings. The patented CLO-D technology has been shown to be capable of killing many deadly bacterial and viral substances such as anthrax and H1N1 in buildings while they are still occupied. The CLO-D technology has been laboratory and field tested and the Company believes that use of the technology can provide a marked improvement in air quality and eliminate many of the most dangerous airborne bacteria, viruses, and pollutants. For additional information about CLO-D technology and Press Ventures, please visit

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, interest by potential customers to test CLO-D technology, demand for natural biosafety solutions, exploitation of business opportunities, strategic business goals, rise in diseases, capability of the Company's technology and market information. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products or technologies and operating as a development stage company, our ability to retain important members of our management team and attract other qualified personnel, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, our ability to develop and commercialize products based on our technology platform, and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at

Contact Information